Ambien vs Trazodone: Switching Between Them Safely
A clinical comparison of zolpidem (Ambien) and trazodone for insomnia, including how to switch between them, efficacy data, side-effect profiles, and practical guidance for patients and prescribers.
Synthroid vs Armour Thyroid: How to Switch Between Them Safely
A clinical guide to switching between Synthroid (levothyroxine) and Armour Thyroid (desiccated thyroid extract), covering dose conversion, monitoring timelines, and which patients benefit from each formulation.
Synthroid vs Cytomel (Liothyronine): Switching Between Them
A guide to switching between levothyroxine (Synthroid) and liothyronine (Cytomel), including dose conversion, monitoring protocols, and what the evidence says about T4 monotherapy versus T3 addition.
Oral Estradiol vs Prometrium: Cost, Access, and Clinical Comparison
A head-to-head look at oral estradiol and Prometrium (micronized progesterone) covering price, insurance coverage, pharmacy availability, and how the WHI and PEPI trial evidence does and does not apply to this drug pair.
Oral Estradiol vs Prometrium: Switching Between Them
Oral estradiol and Prometrium (micronized progesterone) serve different roles in menopausal HRT. Learn when and how clinicians switch or adjust these components, what the trials show, and how to manage transitions safely.
Estradiol Patch vs. Oral Estradiol: Switching Between Them
A clinical guide to switching between transdermal estradiol patches and oral estradiol tablets, covering dose equivalence, safety differences, and step-by-step protocols.
Estradiol Patch vs Vaginal Estradiol: Cost, Access, and Clinical Comparison
A head-to-head comparison of estradiol transdermal patches and vaginal estradiol covering cost, insurance access, systemic absorption, clinical evidence, and prescribing guidance for menopausal hormone therapy.
Estradiol Patch vs Vaginal Estradiol: Switching Between Them
A clinical comparison of transdermal estradiol patches and vaginal estradiol, including when and how to switch between them, systemic vs local effects, and what the evidence says about each route.
Oral Micronized Progesterone vs Prometrium: Cost and Access Head-to-Head
Oral micronized progesterone and Prometrium are the same molecule. This guide breaks down brand vs generic cost, insurance coverage, pharmacy access, and clinical equivalence for women on HRT.
Oral Micronized Progesterone vs Prometrium: Side-Effect Profile Head-to-Head
Oral micronized progesterone and Prometrium contain the identical active ingredient. This clinical comparison breaks down whether brand vs generic formulation differences affect side effects, tolerability, and safety.
Oral Micronized Progesterone vs Prometrium: Switching Between Them
Oral micronized progesterone and Prometrium are the same active drug. Learn what differs between generic and brand formulations, how to switch safely, and what clinicians monitor during transitions.
Prometrium vs Vaginal Estradiol: Cost and Access Head-to-Head
A clinical comparison of Prometrium (micronized progesterone) and vaginal estradiol covering cost, insurance access, indications, and prescribing strategy for women's HRT.
Addyi vs Vyleesi: Switching Between Flibanserin and Bremelanotide for HSDD
A clinical comparison of Addyi (flibanserin) and Vyleesi (bremelanotide) for hypoactive sexual desire disorder, including when and how to switch between them safely.
Exercise Prescription for Established Cardiovascular Disease
Evidence-based exercise protocols for patients with established cardiovascular disease, including post-MI, stroke, PAD, and coronary artery disease. Covers cardiac rehab phases, intensity targets, and safety monitoring.
Established Cardiovascular Disease Guidelines Compared: ADA, AACE, Endocrine Society, and More
Compare current ADA, AACE, Endocrine Society, and ACC/AHA recommendations for LDL cholesterol, blood pressure, GLP-1 therapy, and established heart disease.
Established Cardiovascular Disease and Mental Health: The Clinical Overlap
Depression, anxiety, and PTSD occur at 2-3x the general population rate in patients with established cardiovascular disease. Evidence-based screening and treatment reduce both psychiatric burden and recurrent MACE.
Male Hypogonadism: Common Comorbidities and Clinical Overlap
Male hypogonadism shares strong bidirectional links with obesity, type 2 diabetes, metabolic syndrome, cardiovascular disease, osteoporosis, and depression. Learn how these conditions overlap and what guidelines recommend.
Male Hypogonadism: Nutrition and Lifestyle Protocols That Support Testosterone
Weight loss is linked to higher testosterone in men with obesity. See what studies show for vitamin D, zinc, sleep apnea and exercise.
Male Hypogonadism Treatment Algorithm: A Line-by-Line Therapy Guide
A step-by-step guide to confirming male hypogonadism, identifying its cause, choosing fertility-focused treatment or TRT, and tracking treatment response.
Menopause Caregiver and Family Resources
Evidence-based guide for caregivers and family members supporting someone through menopause, including communication strategies, treatment literacy, and when to seek help.
Menopause Diagnosis: 12-Month Rule, FSH Levels & Criteria
Menopause is diagnosed after 12 months in a row with no period. Blood hormone tests are usually not needed, and no FSH level confirms it.
Menopause Exercise Prescription: Evidence-Based Protocols for Symptom Relief and Long-Term Health
A clinical guide to exercise protocols during menopause, covering resistance training, aerobic activity, and bone-loading strategies, with an honest account of what trial evidence does and does not establish.
Menopause Treatment Algorithm by Line of Therapy
Evidence-based, step-by-step menopause treatment algorithm organized by line of therapy. Covers HRT, non-hormonal options, and bone-protective strategies per Endocrine Society, NAMS, and ACOG guidelines.
Menopause-Related Weight Gain: Caregiver and Family Resources
Evidence-based resources for caregivers and families supporting someone through menopause-related weight gain, including treatment options, diagnostic criteria, and practical support strategies.
Menopause-Related Weight Gain: Common Comorbidities and Clinical Overlap
An evidence-based guide to the comorbidities linked to menopause-related weight gain, including type 2 diabetes, cardiovascular disease, metabolic syndrome, MASLD, and osteoporosis, with society guideline recommendations.
Menopause-Related Weight Gain Diagnostic Algorithm: A Step-by-Step Clinical Approach
A step-by-step diagnostic algorithm for menopause-related weight gain, covering hormonal evaluation, metabolic screening, body composition assessment, and evidence-based next steps grounded in Endocrine Society, AACE, and ADA guidelines.
Menopause-Related Weight Gain: Emerging Research and Trials to Watch
A clinical review of the latest research on menopause-related weight gain, including GLP-1 receptor agonist trials, hormone therapy data, and investigational therapies reshaping treatment in 2025 and beyond.
Exercise Prescription for Menopause-Related Weight Gain
Evidence-based exercise protocols for managing weight gain during menopause, including resistance training, aerobic programming, and HIIT, with doses and timelines from major clinical trials.
Metabolic Syndrome: Common Comorbidities and Clinical Overlap
A clinical guide to the conditions that cluster with metabolic syndrome, including type 2 diabetes, cardiovascular disease, NAFLD, PCOS, and sleep apnea, with evidence-based management strategies.
Metabolic Syndrome Genetics and Family History: What Your DNA Actually Determines
How genetics and family history shape metabolic syndrome risk, which gene variants matter most, and what clinicians recommend for people with inherited predisposition.
NAFLD / MASLD and Mental Health: The Overlap Between Liver Disease and Depression, Anxiety, and Cognitive Decline
NAFLD and MASLD are linked to higher rates of depression, anxiety, fatigue, and cognitive impairment. Learn how metabolic liver disease affects mental health and what treatments address both conditions.
Obesity (BMI ≥30) Caregiver and Family Resources
Evidence-based guide to caregiver support, family-based interventions, and practical resources for managing obesity (BMI ≥30), including behavioral strategies, medication awareness, and clinical guidelines from ADA, AACE, and the Endocrine Society.
Obesity (BMI ≥30): Emerging Research and Trials to Watch
A clinical review of the most promising obesity trials, next-generation GLP-1 receptor agonists, combination therapies, and gene-based approaches reshaping how we treat BMI ≥30.
Obesity Genetics and Family History: What Your DNA Means for Weight and Treatment
How genetics and family history influence obesity risk, BMI heritability, known gene variants like MC4R and FTO, and what this means for GLP-1 and other treatments.
Psychological Monitoring for Obesity Medications
Obesity raises depression risk 55%; depression raises obesity risk 58%. Learn what to monitor and how to treat both conditions together.
Exercise Prescription for Obstructive Sleep Apnea (OSA): Evidence-Based Protocols
Structured exercise programs reduce OSA severity by 25-50% even without weight loss. Review the evidence on aerobic, resistance, and oropharyngeal training protocols for AHI reduction.
OSA Follow-Up Schedule: 30 Days, 3 Months, Then Annually
Sleep apnea follow-up care: CPAP check at 30 days, clinical review at 3 months, then every 6-12 months with annual cardiometabolic screening.
Obstructive Sleep Apnea Nutrition and Lifestyle Protocols
Evidence-based nutrition, weight-management, and lifestyle interventions for obstructive sleep apnea (OSA), including dietary patterns, GLP-1 receptor agonists, exercise protocols, and positional therapy.
PCOS Comorbidities: The Conditions That Overlap With Polycystic Ovary Syndrome
PCOS raises risk for type 2 diabetes, cardiovascular disease, NAFLD, depression, and more. Learn which comorbidities to screen for, when, and how current guidelines direct treatment.
PCOS Diagnostic Algorithm: A Step-by-Step Clinical Guide
Step-by-step PCOS diagnostic algorithm based on Rotterdam criteria, Endocrine Society guidelines, and AE-PCOS Society recommendations. Covers hyperandrogenism testing, ovulatory assessment, ultrasound criteria, and phenotype classification.
PCOS Genetics and Family History: What Runs in Families and What It Means for You
PCOS has a strong genetic component, with heritability estimates of 70%. Learn how family history shapes risk, which genes are involved, and how diagnosis and treatment strategies adapt when PCOS runs in your family.
PCOS Monitoring Schedule: Exact Lab Tests, Timelines, and Follow-Up Intervals
Evidence-based PCOS monitoring schedule with specific lab tests, imaging timelines, and follow-up intervals recommended by the Endocrine Society, ADA, and AACE guidelines.
Perimenopause Exercise Prescription: Evidence-Based Protocols for the Menopausal Transition
A clinical guide to resistance training, high-intensity intervals, and bone-loading exercise during perimenopause, with an evidence-boundary map and a clinician-discussion framework for individualizing the protocol.
Post-Surgical Recovery: Common Comorbidities and Overlap
Comorbidities like diabetes, obesity, depression, and venous thromboembolism complicate post-surgical recovery. Learn how overlapping conditions affect healing timelines, complications, and treatment planning.
Recovery Protocol by Phase After Surgery
Post-surgical recovery protocol covers three phases: early mobilization (days 0-7), progressive loading (weeks 2-6), and return-to-activity training (weeks 6-12).
Post-Surgical Recovery Monitoring Schedule: Week-by-Week Clinical Timeline
A precise, week-by-week monitoring schedule for post-surgical recovery covering labs, wound checks, pain assessment, nutritional support, and when to escalate care.
Prediabetes Nutrition and Lifestyle Protocols: Evidence-Based Strategies to Prevent Type 2 Diabetes
Complete guide to prediabetes nutrition protocols, lifestyle interventions, and pharmacotherapy options backed by the Diabetes Prevention Program and ADA guidelines.
Secondary Hypogonadism Diagnostic Algorithm: A Step-by-Step Clinical Guide
A step-by-step diagnostic algorithm for secondary hypogonadism, covering morning testosterone testing, LH/FSH interpretation, pituitary imaging, and when to refer, grounded in Endocrine Society and AUA guidelines.
Secondary Hypogonadism: Emerging Research and Trials to Watch
A clinical review of the latest trials, investigational therapies, and guideline updates reshaping how secondary hypogonadism is diagnosed and treated, including oral enclomiphene, kisspeptin agonists, and selective androgen receptor modulators.
Secondary Hypogonadism: Genetics and Family History
How inherited gene variants and familial patterns contribute to secondary hypogonadism, what genetic tests are available, and when clinicians should suspect a hereditary cause.
Secondary Hypogonadism Monitoring Schedule: Lab Tests, Timing, and Follow-Up Protocol
Evidence-based monitoring schedule for secondary hypogonadism, including lab timing, hormone targets, and follow-up intervals from the Endocrine Society, AUA, and AACE guidelines.
Secondary Hypogonadism in Special Populations: Diagnosis, Treatment & Guidelines
How secondary hypogonadism presents and is managed in obesity, type 2 diabetes, opioid use, HIV, CKD, and other special populations. Evidence-based guidance from the Endocrine Society, ADA, and AACE.
Secondary Hypogonadism Treatment Algorithm by Line of Therapy
Evidence-based treatment algorithm for secondary hypogonadism, organized by line of therapy. Covers lifestyle modification, clomiphene, enclomiphene, hCG, and testosterone replacement, with attention to what is guideline-supported versus what still needs verification.
Tendinopathy Diagnostic Algorithm: A Step-by-Step Clinical Approach
A structured, evidence-based algorithm for diagnosing tendinopathy. Covers clinical history, physical examination, imaging, and differential diagnosis across Achilles, patellar, rotator cuff, and lateral elbow tendons.
Tendinopathy Exercise Prescription: Evidence-Based Protocols for Every Major Tendon
A guide to exercise-based treatment for tendinopathy, covering eccentric loading, heavy slow resistance, isometric protocols, and progression criteria for Achilles, patellar, rotator cuff, and lateral elbow tendons.
Tendinopathy Nutrition and Lifestyle Protocols
Evidence-based nutrition, supplementation, and lifestyle strategies for tendinopathy recovery. Covers collagen synthesis support, load management, anti-inflammatory dietary patterns, and emerging therapies like BPC-157 and PRP.
Type 2 Diabetes Caregiver and Family Resources
Evidence-based guide to caregiver support, family involvement strategies, and community resources for managing Type 2 Diabetes at home.
Type 2 Diabetes Comorbidities: The Conditions That Travel With T2D
A clinical guide to the most common comorbidities linked to type 2 diabetes, including cardiovascular disease, CKD, MASLD, obesity, hypertension, depression, and sleep apnea, with evidence-based screening recommendations.
Two Abnormal Tests, Same Sample: Diabetes Confirmed?
Yes, if two different tests from the same sample both exceed threshold, ADA criteria confirm diabetes. See HbA1c, FPG, and OGTT cutoffs plus screening ages.
Type 2 Diabetes and Mental Health: The Clinical Overlap Between Depression, Anxiety, and Glycemic Control
Depression and anxiety are 2-3x more common in adults with type 2 diabetes. Learn how the bidirectional relationship affects HbA1c, treatment options, and screening guidelines from the ADA and APA.